
Patients with hidradenitis suppurativa expressed six emergent themes that impact their access to proper health care, according to a study.
“People with [hidradenitis suppurativa (HS)] face considerable challenges to health care access, with the average patient experiencing a diagnostic delay of 7 to 10 years,” Leandra A. Barnes, MD, of the department of dermatology at Stanford Medicine, and colleagues wrote. “Additionally, poor understanding of HS biology has limited the development of effective treatments, thereby contributing to substantial quality-of-life impairment.”